Diebold Nixdorf Incorporated (NYSE:DBD) does about 1.85M shares in volume on a normal day but saw 1862545 shares change hands in Monday trading. The company now has a market cap of 178.88M USD. Its current market price is $2.38, marking an increase of 7.69% compared to the previous close of $2.21. The 52 week high reached by this stock is $10.10 whilst the lowest price level in 52 weeks is $1.26. The script in recent trading has seen the stock touch a high of $2.50 and a low of $2.24.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
Diebold Nixdorf Incorporated (DBD) has a 20-day trading average at $1.69 and the current price is -76.44% off the 52-week high compared with 88.89% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.89 and its 200-day simple moving average is $2.93. If we look at the stock’s price movements over the week, volatility stands at 9.71%, which decreases to 8.55% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 71.79 to suggest the stock is overbought.
The consensus objective for the share price is $4.00, suggesting that the stock has a potential upside of 40.5% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 24, 2022 when DA Davidson downgraded the stock to “Neutral” and issued a price target of between $5 and $3. Wedbush upgraded its price target at $5.
The current price level is 44.95%, 26.02%, and -19.25% away from its SMA20, SMA50, and SMA200 respectively, with the DBD price moving below the 50-day SMA on January 23. Diebold Nixdorf Incorporated (DBD) stock is up 27.96% over the week and 84.50% over the past month. Its price is 67.61% year-to-date and -75.46% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2022, with the company’s earnings per share (EPS) of $0.38 above consensus estimates by $0.52. DBD’s earnings per share are forecast to shrink by -158.80% this year and 372.30% over next year. Expected sales for next quarter are $979.9 million, which analysts say will come at $3.49 billion for the current fiscal year and next year at $3.72 billion. In addition, estimates put the company’s current quarterly revenue at an average of $843.46 million.
To reach the target analysts have set, the stock logically needs to grow 40.5 percent from here.
Outstanding shares total 79.10M with insiders holding 9.70% of the shares and institutional holders owning 83.98% of the company’s common stock. The company has a return on investment of 7.50% and return on equity of 42.30%. The forward price to earnings ratio is 1.62. The beta has a value of 2.99. Price to sales ratio is 0.05.
Vanguard Total Stock Market Index isn’t the only investment manager who changed stakes and is followed by iShares Russell 2000 ETF, which sold off 16897.0 shares to end up with 1,617,149 shares worth $15.03 million. 1290 VT GAMCO Small Company Value cut their holdings by -18.24% in the company over the course of the most recent quarter. It now holds a 1.76% position in Diebold Nixdorf Incorporated thanks to 1.39 million shares amounting to $12.92 million.